Transaction · 0001415889-25-002207

Morrell Martha

Morrell Martha, CMO, reported an open-market or private sale at NeuroPace Inc involving 3200.000000 shares for an estimated $48032.00. Reported holdings after the transaction were 87062.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCMO
NPCENeuroPace Inc
Filing timeJan 28
Trade dateJan 24, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NPCE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NPCE since 2025-01-28Filed 585 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-002207
Common Stock
Transaction date
Jan 24, 2025
Filed Jan 28, 2025, 11:08 PM · 4d delay
Shares
3.20k sh
$1.50k per share
Estimated value
-$4.80M
Computed from shares × price
Holdings after
87.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF MEDICAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provi…

Original filing · 0001415889-25-002207
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NPCE